Longtime drug developer Suma Krishnan was 51 when she cofounded Krystal Biotech. Now the company has one gene therapy on the market and more in the works.| Forbes
Software developers are often frustrated by obscure pricing plans for the AI coding tools they use. With $27 million in new funding, Cline is developing tools to help them manage their AI bills.| Forbes
Since the rise of generative AI, many have feared the toll it would take on the livelihood of human workers. Now CEOs are admitting AI’s impact and layoffs are starting to ramp up.| Forbes